Johnson & Johnson MedTech has completed the first cases in the clinical trial for its OTTAVA Robotic Surgical System.
OTTAVA is a multi-specialty soft-tissue surgery robot designed to address surgical robotics shortcomings and support a broad range of procedures.
The system's unified architecture, surgical instrumentation, and connection to the Polyphonic digital ecosystem aim to meet the needs of each patient's care and surgeon's clinical approach.
Upon completion of the study, Johnson & Johnson plans to submit the OTTAVA system for De Novo authorization in the U.S.